Medicare Enrolled
Dr. John Michalak, M.D.
Urology Physician · Pinehurst, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Michalak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Michalak?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Michalak
Dr. John Michalak is an urology physician in Pinehurst, NC, with 13 years of NPI registration. Based on federal Medicare data, Dr. Michalak performed 7,049 Medicare services across 4,902 unique beneficiaries.
Between the years covered by Open Payments, Dr. Michalak received a total of $9,002 from 44 pharmaceutical and/or device companies across 410 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Michalak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 10% volume in NC
$9,002 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,049
Medicare services
Top 10% in NC for urology physician
4,902
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~542 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,299 | $3 | $22 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
915 | $89 | $371 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
701 | $7 | $75 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
412 | $8 | $23 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
320 | $64 | $272 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
306 | $20 | $109 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 225 | $135 | $919 |
| PSA test (prostate cancer screening) | 218 | $18 | $104 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
179 | $174 | $726 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
173 | $126 | $486 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
122 | $17 | $81 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
122 | $108 | $499 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
121 | $93 | $289 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
116 | $8 | $37 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
115 | $29 | $236 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
109 | $10 | $78 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
108 | $21 | $106 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
108 | $4 | $37 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
97 | $48 | $333 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
96 | $5 | $31 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
92 | $123 | $1,078 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
92 | $5 | $152 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
79 | $19 | $85 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
77 | $67 | $384 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
76 | $56 | $300 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
74 | $105 | $435 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
50 | $591 | $3,406 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
47 | $129 | $515 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
45 | $25 | $119 |
| Simple change of bladder tube | 43 | $68 | $384 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
42 | $190 | $1,137 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
39 | $80 | $1,709 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
39 | $302 | $1,799 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
38 | $25 | $580 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
37 | $230 | $1,188 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
34 | $76 | $586 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
29 | $553 | $2,795 |
| CT scan of abdomen with and without contrast A CT scan of the abdomen performed both before and after the administration of contrast dye to provide detailed images of internal structures. |
29 | $134 | $810 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
28 | $73 | $328 |
| Voiding cystourethrogram An imaging procedure that uses X-rays to visualize the bladder and urethra while urine is being passed. |
26 | $91 | $707 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
25 | $169 | $851 |
| Radiologist review of bladder and urethra images with contrast A radiologist reviews medical images of the urinary bladder and urethra taken with contrast dye, including images captured after the patient has urinated. |
24 | $80 | $347 |
| Endoscopic removal of urethral or bladder foreign body A procedure to remove a stone, stent, or other object from the urethra or bladder using an endoscope. The endoscope allows the provider to visualize and extract the item through the urinary tract. |
23 | $361 | $1,831 |
| Endoscopic repair of ureteral stricture A procedure to widen or fix a narrowed section of the ureter using an endoscope inserted into the body. |
23 | $257 | $1,738 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
20 | $147 | $709 |
| Bladder tumor removal via endoscope This procedure involves using an endoscope to destroy or remove a large growth from the bladder. |
20 | $218 | $1,734 |
| Bladder and urethra clot removal with endoscope A procedure using an endoscope to irrigate and remove multiple blood clots from the bladder and urethra. |
12 | $247 | $1,400 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
12 | $142 | $935 |
| New patient office visit, complex (60-74 min) | 12 | $144 | $596 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
16.1% medium
82.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,002
Total received (2018-2024)
Avg $1,286/year across 7 years
Top 20% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
410
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,553 (95.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$448 (5.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,116
2023
$1,082
2022
$1,510
2021
$2,220
2020
$1,102
2019
$1,443
2018
$529
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$313
Dendreon Pharmaceuticals LLC
$187
PFIZER INC.
$137
ABBVIE INC.
$114
Janssen Biotech, Inc.
$79
Endo USA, Inc.
$78
PROCEPT BioRobotics Corporation
$65
Endo Pharmaceuticals Inc.
$56
Myriad Genetic Laboratories, Inc.
$34
Teleflex LLC
$20
Laborie Medical Technologies Corp.
$18
Axonics, Inc.
$15
Top 3 companies account for 57.1% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,287
Endo Pharmaceuticals Inc.
$906
Dendreon Pharmaceuticals LLC
$881
PFIZER INC.
$573
Sumitomo Pharma America, Inc.
$533
NeoTract Inc.
$446
Teleflex LLC
$442
Olympus America Inc.
$428
Janssen Biotech, Inc.
$361
Myriad Genetic Laboratories, Inc.
$320
ABBVIE INC.
$276
BOSTON SCIENTIFIC CORPORATION
$261
AbbVie Inc.
$220
Axonics, Inc.
$219
Laborie Medical Technologies Corp.
$216
UROVANT SCIENCES INC
$207
Boston Scientific Corporation
$186
PROCEPT BioRobotics Corporation
$118
DENTSPLY IH Inc.
$114
AbbVie, Inc.
$100
GENZYME CORPORATION
$86
Endo USA, Inc.
$78
Dornier MedTech America, Inc
$64
Aytu BioScience, Inc
$55
Bayer HealthCare Pharmaceuticals Inc.
$53
Photocure Inc
$50
Ethicon US, LLC
$48
UroGen Pharma, Inc.
$47
Avadel Specialty Pharmaceuticals, LLC
$43
Myovant Sciences Inc.
$41
Allergan, Inc.
$39
Coloplast Corp
$38
UROGEN PHARMA, INC.
$37
Sun Pharmaceutical Industries Inc.
$35
Progenics Pharmaceuticals, Inc.
$33
Allergan Inc.
$25
Antares Pharma, Inc.
$23
180 Medical, Inc.
$19
Smith+Nephew, Inc.
$18
DENTSPLY IH AB
$18
Cook Medical LLC
$16
AstraZeneca Pharmaceuticals LP
$15
Hollister Incorporated
$14
Acerus Pharmaceuticals Corporation
$12
Top 3 companies account for 34.1% of all-time payments
Associated products mentioned in payments ›
ALTIS · AMS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Axonics · Axonics r-SNM System · BOTOX · BRAC CDx · BRACANALYSIS CDX · BRACAnalysis CDx · Consumables & Accessories · Cook Medical Lasers · Cysview · ERLEADA · Echelon Powered Circular · Enseal X1 · FEMALE INCONTINENCE · GEMTESA · GENERAL ERECTILE DYSFUNCTION · Infyna Chic · JELMYTO · JEVTANA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · Natesto · Noctiva · Nubeqa · ORGOVYX · Olympus · Olympus Laser Devices · Optilume BPH Drug Coated Balloon Catheter · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · STRAVIX · TOVIAZ · UROLIFT · UroLift · UroLift 2 System · UroLift System · VESICARE · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
10
Per 100K population
9.7
County median income
$82,837
Nearest hospital
FIRSTHEALTH MOORE REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Michalak is a clinical cardiology specialist, with above-average Medicare volume (top 10% in NC), with low-engagement industry engagement in the top 20% of NC peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Michalak experienced with urinalysis with microscopic exam?
Based on Medicare claims data, Dr. Michalak performed 1,299 urinalysis with microscopic exam services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Michalak receive payments from pharmaceutical companies?
Yes. Dr. Michalak received a total of $9,002 from 44 companies across 410 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Michalak's costs compare to other urology physicians in Pinehurst?
Dr. Michalak's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Michalak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Pinehurst
Browse urology physicians in Pinehurst ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology